ERHART, C.-C.; Cefalì M.; MANGAN , D.; KASENDA , B.; WANNESSON, L. Prognostic value of KRAS G12C in advanced non-small cell lung cancer with high PD-L1 expression treated with upfront immunotherapy: a systematic review and meta-analysis. Swiss Medical Weekly, [S. l.], v. 154, n. 7, p. 3695, 2024. DOI: 10.57187/s.3695. Disponível em: https://smw.ch/index.php/smw/article/view/3695. Acesso em: 6 oct. 2024.